These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 19184651)
1. The neuronal pathways mediating the behavioral and addictive properties of nicotine. Balfour DJ Handb Exp Pharmacol; 2009; (192):209-33. PubMed ID: 19184651 [TBL] [Abstract][Full Text] [Related]
2. The role of mesoaccumbens dopamine in nicotine dependence. Balfour DJ Curr Top Behav Neurosci; 2015; 24():55-98. PubMed ID: 25638334 [TBL] [Abstract][Full Text] [Related]
3. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain. Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313 [TBL] [Abstract][Full Text] [Related]
5. The role of the cannabinoid system in nicotine addiction. Castañé A; Berrendero F; Maldonado R Pharmacol Biochem Behav; 2005 Jun; 81(2):381-6. PubMed ID: 15925402 [TBL] [Abstract][Full Text] [Related]
6. Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence. Balfour DJ Curr Drug Targets CNS Neurol Disord; 2002 Aug; 1(4):413-21. PubMed ID: 12769613 [TBL] [Abstract][Full Text] [Related]
7. CB1 receptor antagonists for the treatment of nicotine addiction. Cohen C; Kodas E; Griebel G Pharmacol Biochem Behav; 2005 Jun; 81(2):387-95. PubMed ID: 15935455 [TBL] [Abstract][Full Text] [Related]
8. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas. Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462 [TBL] [Abstract][Full Text] [Related]
9. Recognising nicotine: the neurobiological basis of nicotine discrimination. Smith JW; Stolerman IP Handb Exp Pharmacol; 2009; (192):295-333. PubMed ID: 19184654 [TBL] [Abstract][Full Text] [Related]
10. Cue reactivity in nicotine and tobacco dependence: a "multiple-action" model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli. Chiamulera C Brain Res Brain Res Rev; 2005 Feb; 48(1):74-97. PubMed ID: 15708629 [TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular mechanisms of action of nicotine in the CNS. Barik J; Wonnacott S Handb Exp Pharmacol; 2009; (192):173-207. PubMed ID: 19184650 [TBL] [Abstract][Full Text] [Related]
13. Nicotine activates and desensitizes midbrain dopamine neurons. Pidoplichko VI; DeBiasi M; Williams JT; Dani JA Nature; 1997 Nov; 390(6658):401-4. PubMed ID: 9389479 [TBL] [Abstract][Full Text] [Related]
14. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Pontieri FE; Tanda G; Orzi F; Di Chiara G Nature; 1996 Jul; 382(6588):255-7. PubMed ID: 8717040 [TBL] [Abstract][Full Text] [Related]
15. Nicotine-induced changes of glutamate and arginine in naive and chronically alcoholized rats: an in vivo microdialysis study. Lallemand F; Ward RJ; Dravolina O; De Witte P Brain Res; 2006 Sep; 1111(1):48-60. PubMed ID: 16884696 [TBL] [Abstract][Full Text] [Related]
16. A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature. DiFranza JR; Wellman RJ Nicotine Tob Res; 2005 Feb; 7(1):9-26. PubMed ID: 15804674 [TBL] [Abstract][Full Text] [Related]
17. High resolution spatial mapping of nicotine action using pharmacologic magnetic resonance imaging. Choi JK; Mandeville JB; Chen YI; Kim YR; Jenkins BG Synapse; 2006 Aug; 60(2):152-7. PubMed ID: 16715493 [TBL] [Abstract][Full Text] [Related]
18. Nicotine differentially affects dopamine transmission in the nucleus accumbens shell and core of Lewis and Fischer 344 rats. Cadoni C; Muto T; Di Chiara G Neuropharmacology; 2009; 57(5-6):496-501. PubMed ID: 19647004 [TBL] [Abstract][Full Text] [Related]
19. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Benowitz NL Am J Med; 2008 Apr; 121(4 Suppl 1):S3-10. PubMed ID: 18342164 [TBL] [Abstract][Full Text] [Related]
20. Mechanism-based medication development for the treatment of nicotine dependence. Xi ZX; Spiller K; Gardner EL Acta Pharmacol Sin; 2009 Jun; 30(6):723-39. PubMed ID: 19434058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]